深圳英迈思文化科技有限公司 Shenzhen British Maisi culture Technology Co., Ltd SINEC2002
Company profile

Company profile

 


Shenzhen Techdow Pharmaceutical Co., Ltd (Techdow) was established in Jun 2004, located in Shenzhen High-tech Industrial Park where was treated as ‘World-class high-tech industrial park’ by Ministry of Science and Technology of China. Through more than 10 years of accumulation and innovation, Techdow has become a large Low Molecular Weight Heparin (LMWH) pharmaceutical enterprise including R&D, manufacture and sales. Techdow uphold the values of ‘Science, Research, Diligence, and Harmony’. Techdow has strong scientific research strength and industrialization capacity, which product has been sold into worldwide. Techdow has established the long term and stable cooperation with more than 50 well-known pharmaceutical companies.

Techdow is the largest LWMH manufacturer and exporter of China. Depending on the strong research strength, leading technology, reliable quality assurance system and excellent industrialization capacity, Techdow’s API product (such as Enoxaparin sodium API) has obtained the GMP certificate from more than 20 authorities including US FDA, EU, Australia TGA, Brazil ANVISA, Colombia INVIMA and so on, Furthermore, Techdow has passed US FDA inspection for API without any deficiency for twice.

Focusing on the business development of heparin and LMWH finished dosage; Techdow has currently become the largest LMWH finished dosage product exporter in China. In 2014, Techow’s Heparin Sodium injection got the US FDA ANDA, becoming the first Chinese Heparin Sodium Injection supplier in American market. In 2016, Techdow obtained marketing authorization of Enoxaparin Sodium injection in EU market, becoming the first Enoxaparin sodium injection generic supplier in EU market. In 2016, our product was launched in Poland, and Techdow UK, Techdow Germany and other European subsidiary were established simultaneously. In 2017, our product was launched in Germany, UK and Italy, the sales volume and market share have been increasing since then, based on the sales channel construction and development and unique product advantages. With its highly efficient and large R & D structure, Techdow has become the cradle of high-quality pharmaceutical products, which further takes its social responsibility for customers, employees, investors and governments through their products and services. Techdow dedicates to become a respectable globalization pharmaceutical enterprise, and make a great contribution to human health.